CPDN is pleased to announce the following appointments to its Board of Directors

Effective Feb 1, 2024, Kirill Vendrov, currently Director, Established Medicines Group & Corporate Accounts at Johnson & Johnson Innovative Medicine, is appointed CPDN Board Chair responsible for leading the CPDN Board in carrying out its corporate governance and fiduciary duties. Kirill has served on the CPDN Board since 2020 and brings a wealth of knowledge and experience in pharmaceutical supply chain and commercial strategy.

Read More

Sav DiPasquale, President, CPDN, asked to join the SCAN Health

CPDN is pleased to announce that Sav DiPasquale, President, CPDN, has been asked to join the SCAN Health (Supply Chain Advancement Network in Health) on their Leadership & Policy Community of Practice workgroup. This workgroup will examine leadership and policy frameworks to advance and support supply chain resilience, cooperation and transparency across jurisdictional borders, teams, and agencies.

Read More

Introducing our new Director, Customer Service, Caroline Lalonde

Please join me in welcoming Caroline Lalonde as our new Director, Customer Service for CPDN. Caroline joins us with over 20 years of experience in the healthcare sector working for both private and not-for-profit companies in a variety of senior leadership roles including business and client growth strategist, patient advocacy and public policy lead, stakeholder relations, business development, customer service and healthcare program management.  Her expertise spans key competencies such as healthcare strategic planning, national product sales, launches and logistics, policy development, manufacturer relationship management, developing innovative patient solutions and customer engagement. Caroline is fluently bilingual and resides in Mississauga.

Read More

COVID-19 CPDN President’s letter to Buyers

As the COVID-19 pandemic continues across Canada, I wanted to reach out to you on two fronts. Firstly, on behalf of the CPDN team, its strategic service partners, and member manufacturers, I wanted to extend our sincerest gratitude for your dedicated and tireless efforts in providing an essential service to ensure that patients in hospitals had access to essential medicines during the first wave of the pandemic.

Read More